The most defensible estimated net worth range for Dr. Richard Park, co-founder and founding CEO of CityMD, is somewhere between $50 million and $150 million, with the upper end more plausible if his equity position at the time of the 2017 sale was substantial. That range is not a precise figure, it is an inference built from documented events, physician-executive compensation benchmarks, and what we know about the $600 million acquisition by Warburg Pincus. Here is how to think through that number honestly.
Richard Park CityMD Net Worth: How to Estimate Reliably
Marcus Holloway
12 Apr 2026
Who Richard Park (CityMD) is and why people search his net worth
Richard Park, MD, FACEP, is a board-certified emergency medicine physician who co-founded CityMD in New York City in August 2010 alongside a group of physician partners. He served as the company's Founding CEO from launch through August 2021, building what became one of the largest urgent care networks in the northeastern United States. Press materials from 2014 quote him as 'CEO of CityMD,' and a Warburg Pincus investment announcement explicitly names 'Richard Park and other physician partners' in connection with the 2010 founding. He also chaired the nonprofit CityMD Cares Inc., according to ProPublica records, and after leaving the operator role he went on to co-found Ascend Partners, a private equity firm focused on healthcare, in 2019. By 2021 he was listed as Co-Founder and Managing Partner of Ascend Partners and a new trustee of the New York Academy of Medicine.
Net worth curiosity here is almost entirely driven by one event: CityMD was sold in 2017 for $600 million to Warburg Pincus. Any physician-founder who held a meaningful equity stake in that transaction would have realized a significant liquidity event. That is the headline figure that makes people wonder what Dr. Park personally walked away with, and it is also the central unknown, because private-company equity splits are not publicly disclosed.
One important note on disambiguation: 'Richard Park' is a genuinely common name, and a physician named Richard Park, MD appears in multiple healthcare contexts. The specific individual tied to CityMD is consistently identified through a cluster of identifiers: board-certified emergency medicine, CityMD co-founder role, New York City location, and the later Ascend Partners affiliation. Always confirm all four before treating a data point as relevant.
What net worth estimates can and can't tell you
Net worth, at its most basic, is total assets minus total liabilities. For someone like Dr. Park, assets would include post-transaction investment proceeds, real estate, ongoing fund stakes through Ascend Partners, and any retained equity in follow-on ventures. Liabilities would include mortgages, business debt, and any personal guarantees. Net worth is not the same as income, and it is not the same as the gross purchase price of the company he helped sell.
What these estimates cannot tell you: the exact equity percentage Dr. Park held, whether proceeds were reinvested (reducing liquid wealth but not reducing net worth if valuations hold), what his tax liability was on the sale, or whether he has significant debt obligations. Aggregator sites, including this one, work from observable signals and publicly available anchors, then apply reasonable assumptions. That means the figure you see is a range inference, not an audited balance sheet. The transparency about that process is what separates a credible estimate from a fabricated one.
How CityMD physician income is actually structured
Understanding the income structure is essential to understanding where the wealth comes from. For a typical employed urgent care physician at CityMD, compensation follows a familiar model: base salary, productivity bonuses tied to patient volume or RVUs (relative value units), and benefits. Employed emergency medicine physicians in major metro markets earned between $300,000 and $450,000 annually as of the mid-2020s, with urgent care roles generally at the lower end of that band.
But Dr. Park was not just an employed physician, he was a founder and equity-holding CEO. That changes the math entirely. Physician-founders in urgent care networks that scale to acquisition often hold equity stakes ranging from a few percent to double digits depending on how many rounds of dilution occurred. At a $600 million exit, even a 5 percent stake yields $30 million in gross proceeds before taxes. A 15 to 20 percent founder's stake would put pre-tax proceeds in the $90 to $120 million range. Neither figure is confirmed publicly, but the range they produce is the foundation for any serious net worth estimate.
Beyond the sale, his role as Managing Partner at Ascend Partners from 2019 onward introduces carried interest income, management fees, and co-investment returns. A Form D filing for Ascend SMG Co-Invest 1, L.P. lists him as an Executive, confirming active deal-making. This ongoing investing activity means his net worth is not static, it continues to evolve based on portfolio performance.
Where net worth numbers usually come from
For a private-market figure like Dr. Park, net worth aggregators pull from several categories of public data:
- Corporate filings: Form D filings with the SEC (like the Ascend SMG Co-Invest 1 filing) confirm entity affiliations and fundraising activity, though not personal wealth directly.
- Real property records: County recorder databases show property purchases, sale prices, and mortgage balances — one of the few hard asset anchors available for private individuals.
- Court records and judgments: Bankruptcy filings, tax liens, and civil judgments can surface liabilities that reduce net worth.
- Professional signals: Leadership titles, board roles (such as Chair of CityMD Cares Inc. per ProPublica), and public-company affiliations provide career-stage and compensation-tier context.
- Press and transaction announcements: The 2017 $600 million Warburg Pincus acquisition is the single most important anchor here — it sets the ceiling on equity-based wealth.
- Industry compensation benchmarks: Emergency medicine and healthcare executive salary surveys provide baseline salary assumptions for pre-exit income estimates.
What aggregators typically cannot access for private individuals: personal tax returns, private equity fund K-1 distributions, private bank account balances, or the actual equity cap table from the CityMD sale. This is why every figure in this category carries a confidence range, not a single number.
How to research Richard Park specifically without hitting the wrong person
Name disambiguation is a real challenge here. 'Richard Park' and 'Rich Park' return results for multiple professionals. To stay on target, anchor every data point to at least two of the following: CityMD (by name), Ascend Partners, emergency medicine specialty, New York City location, and the 2010 founding date. Any source missing at least two of these should be treated as unverified.
- Start with the SEC's EDGAR full-text search for 'Richard Park' filtered to Form D filings — this surfaces the Ascend-related entity and confirms his executive status in fund vehicles.
- Run a county property records search in New York City (Manhattan, Brooklyn, Queens) using both 'Richard Park' and 'Richard Park MD' as grantor/grantee names. The NYC ACRIS database is free and searchable.
- Search ProPublica's Nonprofit Explorer for 'CityMD Cares' to verify his chair role and review the organization's 990 filings for any compensation disclosures.
- Review press releases on GlobeNewswire and PRWeb using 'Richard Park CityMD' as your search string — these anchor his titles and dates independently of aggregator sites.
- Cross-check CB Insights and LinkedIn for his Ascend Partners role to confirm ongoing investment activity post-CityMD.
- Look up court records in New York state (NYSCEF) to check for any civil litigation that might surface financial details.
- Once you have anchored sources, compare against net worth aggregator estimates and flag any figure that doesn't cite at least one of the above data types.
It also helps to look at comparable physician-founders for calibration. For example, Tim Barry of Village MD represents a similar profile, physician-adjacent executive in the urgent care space, and provides a useful peer benchmark for what founder-level outcomes look like in this sector. Similarly, examining Ron Caplan's net worth at PMC offers context on how private medical company leaders' wealth gets estimated when transaction data is available but equity splits are not disclosed.
How to interpret and verify a net worth estimate
Judging confidence levels
A high-confidence estimate has at least one hard anchor, a documented transaction price, a property record with a specific dollar value, a public-company SEC filing with disclosed compensation. A medium-confidence estimate uses industry salary benchmarks and one or two soft signals like job title and employer. A low-confidence estimate is essentially a salary-tier guess with no transaction anchor. For Dr. Park, the $600 million CityMD sale is a hard anchor for the ceiling, but the equity percentage is unknown, making this a medium-to-high confidence estimate depending on what property or legal records you can add.
Red flags in published estimates
- A round number with no methodology explanation (e.g., '$10 million' with no sourcing) — almost always a guess.
- Conflation of the CityMD sale price with personal net worth (a $600 million company sale does not mean the founder has $600 million).
- No disambiguation from other Richard Parks — if the source doesn't mention CityMD or emergency medicine, it may be profiling the wrong person.
- Figures that haven't been updated since 2017 or earlier, missing the Ascend Partners chapter of his career.
- Sites that list an exact figure without any range — net worth for private individuals is inherently approximate.
What the estimate likely includes and excludes
| Component | Likely Included | Likely Excluded or Unknown |
|---|---|---|
| CityMD equity proceeds (post-2017 sale) | Yes, as primary anchor | Exact percentage and tax treatment |
| Real estate holdings | If property records are public and located | Properties held through LLCs or trusts |
| Ascend Partners carried interest | Partially, based on fund size signals | Actual fund performance and distributions |
| Pre-exit physician/executive salary (2010–2017) | Usually estimated from benchmarks | Actual W-2 or K-1 figures |
| Liabilities (mortgages, business debt) | Sometimes, if court/property records surface them | Private loans and guarantees |
| Post-2021 investment returns | Rarely included in older estimates | Ongoing portfolio gains/losses |
Practical next steps and how to put it in context
If you are trying to arrive at the most defensible figure today, April 2026, here is the honest answer: Dr. Richard Park's estimated net worth is most likely in the $50 million to $150 million range. The lower bound assumes a minority equity stake in the 2017 sale plus accumulated salary and investments. The upper bound assumes a larger founder's position and successful Ascend Partners portfolio performance over six-plus years. If public property records or SEC filings surface specific asset values, those should immediately anchor your revision.
For comparison context within the physician-executive space, it is worth noting how other founder-level medical professionals are valued. Rick Paicius, MD offers a reference point for physician entrepreneurs who have built and exited practices, while the profile of Ward Parkinson of Micron, though from a different sector, illustrates how founder equity compounds over decades for those who stay active in investment roles after their initial exit.
The most important thing to carry forward: do not treat any single published net worth figure as authoritative unless it cites a traceable source. The CityMD sale provides a real and meaningful anchor, Ascend Partners adds ongoing upside, and the gap between those two points is where the estimation work happens. When better data surfaces, a property filing, a fund disclosure, a news interview with financial detail, update the estimate accordingly. That is how responsible aggregation works.
FAQ
Is Richard Park’s net worth basically the $600 million CityMD sale amount?
Net worth and “how much money he made” are different. The sale price of CityMD is the company valuation, not his payout. Your estimate should focus on his equity percentage at the time of the 2017 exit, then subtract taxes and any personal debts that would reduce the final assets he kept.
What is the biggest missing variable in estimating his net worth from the CityMD sale?
Look for evidence of founder equity at exit, typically clues from deal terms (founder shares, option grants, or merger consideration structures) and corroboration from property or investment filings after 2017. Without an equity split, estimates can move by tens of millions, even if you accept the $600 million valuation as the anchor.
If he reinvested sale proceeds, would that make his net worth look lower in estimates?
Try to separate three cash effects, sale proceeds, reinvestments, and timing of taxable events. Reinvesting can reduce liquid cash but not necessarily reduce net worth if the new investment appreciates or is valued at market. Taxes and debt payments do reduce net worth, so they matter more than reinvestment itself.
How should I break down assets and liabilities when doing this type of estimate?
Use the “assets minus liabilities” structure and sanity-check each bucket. Common net worth inputs for someone in his role include real estate (with known assessed or deeded values), taxable investment accounts, and estimated partnership interests. Common liability inputs include mortgages, credit lines, and any personal guarantees tied to business or investment activity.
What should I watch out for when using property records to refine a net worth estimate?
If property records show ownership but not the purchase price, assessed value alone can mislead. A better approach is to look for more than one data point, such as deed history, mortgage amounts, and whether there were refinancing events, then model a range rather than a single point.
Why might his net worth not track his annual income after joining Ascend Partners?
Carried interest and management fees from a private equity firm can create “lumpy” income. That means net worth may rise unevenly after major fundraising or successful exits, so a current snapshot can reflect earlier timing of distributions rather than recent salary.
How much can taxes change the net worth range for founder sale proceeds?
Tax can materially change what sticks, especially with capital gains and state tax differences. If your model assumes no tax, it will usually overshoot. A practical caveat is to apply a conservative tax haircut to the estimated pre-tax proceeds from any equity exit when you cannot confirm his actual tax outcome.
How do I avoid mixing up this Dr. Richard Park with other people of the same name?
Accurate identification is crucial because “Richard Park” appears in multiple healthcare contexts. Your safest rule is to require overlap of at least two anchors from the article’s set, such as CityMD co-founder status plus New York City location, plus the later Ascend Partners connection, before treating any record as relevant.
Why is job title not enough to infer founder-level wealth?
A common mistake is treating a job title like “CEO” as proof of equity magnitude. Titles do not reveal dilution history. Founder equity could be single digits or substantially more depending on rounds, option pools, and how the acquisition structure valued different classes of shares.
What happens if I build an estimate using only physician compensation data?
If you only have salary benchmarks, you should label the result as low-confidence, because salary captures employed income but misses the core wealth driver, founder equity at exit, plus later investment distributions. A better approach is to keep the sale equity as the primary anchor and use salary only as supporting evidence.
How should I interpret changes I see across different net worth websites over time?
Net worth aggregators often update ranges, but many cannot see K-1 details or private account balances. If you see a sudden jump in a published figure, treat it as a re-assumption rather than proof, then confirm whether new property data, filings, or disclosed investment outcomes appear.
How useful are peer net worth comparisons for validating his range?
Compare his scenario to peers only at the “shape” level, not the exact number level. Similar profiles can help you sanity-check founder equity bands and how outcomes scale, but different dilution, timing, and exit structures can make one peer’s result a weak predictor for another.
